New White Paper: Last-mile manufacturing of vaccines
Despite unprecedented efforts to ensure equitable worldwide access to COVID-19 vaccines, the global vaccination effort continues to lag in many low- and middle-income countries. As countries look to optimize their response to the COVID-19 pandemic and advance long-term health security, local manufacturing of vaccines is garnering attention as one part of the solution. In particular, last-mile manufacturing, which refers to localizing the final few steps in the manufacturing process, could help strengthen manufacturing capacity long-term in low- and middle-income countries.
Ten African countries are teaming up with the United Nations Economic Commission for Africa and USP to develop a new framework to streamline how essential medicines are procured. This new framework could help expand access to quality, life-saving medicines for thousands of women and children in Africa.

USP’s Medicine Supply Map enhances transparency of the upstream pharmaceutical supply chain to help identify vulnerabilities and deliver insights that can guide risk mitigation strategies and investment in supply chain resilience.
New field-based method to detect falsified COVID-19 treatment medicine
The USAID-funded and USP-led Promoting the Quality of Medicines Plus (PQM+) program supported development of a field-based test to assess the quality of dexamethasone, a key treatment medicines for COVID-19. Learn more >>
Webinar recap
Creating patient-centered supply chains
In case you missed it, our recent webinar with the Global Health Supply Chain Summit, Palladium, and others unpacked critical issues related to advancing patient-centered pharmaceutical systems and supply chains.